tallimustine has been researched along with cytarabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beran, M; Estey, E; Jeha, S; Kantarjian, H; Keating, M; O'Brien, S; Rios, MB; Vitek, L; Zurlo, MG | 1 |
| Bianchi, N; Borgatti, M; Chiarabelli, C; Fibach, E; Gambari, R; Mischiati, C | 1 |
1 trial(s) available for tallimustine and cytarabine
| Article | Year |
|---|---|
Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cytarabine; Diarrhea; Distamycins; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Leukemia; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Mice; Mice, SCID; Middle Aged; Nausea; Nitrogen Mustard Compounds; Transplantation, Heterologous; Tumor Cells, Cultured; Vomiting | 1997 |
1 other study(ies) available for tallimustine and cytarabine
| Article | Year |
|---|---|
Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine.
Topics: Apoptosis; Blotting, Northern; Cell Differentiation; Cell Division; Cytarabine; Distamycins; DNA-Binding Proteins; Erythrocytes; Fetal Hemoglobin; Globins; Hematopoietic Stem Cells; Hemoglobins; Humans; Hydroxyurea; K562 Cells; Nitrogen Mustard Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2001 |